High Hepatitis B Virus Load in a Patient with Severe Polyarthritis Nodosa by Ghorbani, Gholam Ali et al.
Hepat Mon. 2010; 10(4): 306-309
C  ASE
 REPORT
High Hepatitis B Virus Load in a Patient with Severe Polyarthritis Nodosa
Gholam Ali Ghorbani 1, Gholam Hossein Alishiri 2*, Haddi Khajeh Pour 3
1 Department of Infectious Diseases, Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of 
Medical Sciences, Tehran, IR Iran 
2 Department of Internal Medicine, Rheumatology Ward, Faculty of Medical Sciences, Baqiyatallah University of Medical Sciences, 
Tehran, IR Iran
3 Department of Internal Medicine, Baqiyatallah University of Medical Science, Tehran, IR Iran
Introduction
O
ne  of  the  extra-hepatic  manifestations  of 
hepatitis  B  virus  is  polyarteritis  nodosa 
(PAN). PAN is a rare necrotizing vasculitis that can 
be  progressive  and  fatal.  It  may  be  accompanied 
hepatitis  B  or  C  viral  infection  (1).  Each  of  the 
hepatitis B (HBV), C (HCV) and A viruses (HAV) 
can  cause  extra-hepatic  manifestations  such  as 
PAN,  nephritis  and  meningo-encephalitis  that 
though may be rare, increase the mortality rate (2). 
HBV infection is important in the pathogenesis of 
PAN and accounted for one-third of the cases with 
PAN,  although  higher  prevalence  rates  have  been 
reported from areas with endemic HBV infection. 
In Iran, HBV infection is endemic and thus, PAN 
is  also  more  common  than  other  countries  (3). 
Importantly, the frequency of HBV-PAN decreased 
following improvement in blood safety measures and 
vaccination campaigns (4, 5) which have prolonged 
protection  against  the  virus  and  consequently 
reduced its extra-hepatic complications (6). Immune-
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One of the extra-hepatic manifestations of hepatitis B virus is polyarteritis nodosa (PAN). It may involve medium- and 
small-sized arteries in any organ. Concurrency of these two diseases may be life threatening and both should be treated. 
Herein, we report on a patient with severe PAN and high hepatitis B virus load. The patient was an 18-year-old boy with 
multiple progressive wounds in the skin, referred to our center. The preliminary evaluation showed vasculitis in the skin 
biopsy compatible with PAN. He was treated with low dose prednisolone and lamivudine for three years. However, his 
condition got worse and ulcers on his leg became life threatening. The viral load was 17,000,000 copy/mL. The wound 
developed superimposed resistant bacterial infection. The patient was then treated with two antiviral drugs—lamivudin 
100 mg/day plus adefovir 10 mg/day—and high dose cyclophosphamide (750 mg, once a month) and prednisolone (60 
mg/day for one month). After six months of treatment, viral load decreased to 100,000 copy/mL and wounds healed. 
We concluded that high viral load of hepatitis B virus may play an important role in the severity of PAN. We recommend 
combination therapy with two antiviral agents with high dose of immunosuppressive drugs until both the diseases 
resolve significantly.
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mediated responses to HBV infection can lead to its 
extra-hepatic manifestations that are sometimes life 
threatening (7). Load of HBV may have affect the 
severity of vasculitis; treating of HBV and decreasing 
viral load can help in recovery from vasculitis  (8). 
Herein, we report on a patient presented with severe 
PAN who had high viral load that recovered with 
aggressive antiviral and immunosuppressive therapy.
Case Report
An 18-year-old boy was refereed to our hospital 
with fatigue, malaise, and the skin lesions including 
multiple chronic wounds on his feet and elbows and 
other parts of his body (Figure 1). Wounds began 
three years before and progressed to severe ulcers. 
The preliminary evaluation revealed leucocytoclastic 
vasculitis in the skin biopsy. HBs Ag and HBe Ag 
were positive but serum ALT and AST were normal. 
The patient had been treated with lamivudine (100 
mg/day) and 15 mg/day prednisolone for the last 
three years. There was no response to the treatment 
and lesions progressed to muscle necrosis and even 
invaded bone so that he became candidate for below 
knee  amputation,  as  there  was  circumferential 
necrotizing  lesions  and  cyanotic  ulcers  in  his  leg. 
In re-evaluation for his wounds, smear and culture 
for leishmania, tuberculosis, fungi and malignancy 
were found negative. He had chronic skin lesions 
of molluscum contagiosum which were not active. 
He also had inactive ocular toxoplasmosis that had 
not any complications nor require any therapy. The 
patient had depression for his chronic multiple ulcers 
and the probability of leg amputation if his ulcers 
would not have responded to therapy.
Figure 1. Ulcers on extremities
Laboratory  tests  included  a  WBC  of  10,000/
mm3, ESR of 60 mm/h, and normal serum ALT, 
AST, ALP, and LDH. PPD skin test was negative. LE 
cell, FANA, cANCA, Anti-dsDNA, antiphospholipid 
and complements were normal. Anti-Hbs Ag and 
Hbc Ab were positive; Antibody against HIV and 
HCV were negative. HBV DNA as detected by PCR 
was found positive and revealed a viral load of more 
than 17,000,000 copy/mL using Amplicor test. New 
biopsy of the wounds showed necrotizing vasculitis 
compatible with PAN. Over the recent months, the 
lesions got worse with superimposed infection with 
multiple antibacterial resistant Klebsiella, Actinobacter 
and  Staphylococcus  aureus,  and  therefore,  broad 
spectrum  antibiotics  were  administered.  Infection 
was  eradicated  with  vancomycin  1  g,  bid  plus 
cefepime 1 g, bid given parenterally for one month 
followed by ciprofloxacin 500 mg, bid plus cefixime 
400 mg, qd orally for four months. Anti-viral therapy 
was started with lamivudine plus adefovir in addition 
to immunosuppressive drugs, cyclophsphamide 1 g a 
month and high dose prednisolone (60 mg/day) for 
more than six months when wounds healed (Figure 2) 
and the viral load decreased to 100,000 copy/mL. 
Figure 2. Leg wounds healed 
after therapy
Discussion
In  this  report,  the  extra-hepatic  manifestations 
of HBV infection was multiple cutaneous ulcers on 
extremities and face. The ulcers on the leg were prone 
to necrosis, life threatening and did not recover with 
low dose prednisolone (15 mg/day) and lamivudine. 
Therefore, for the prevention of amputation of his 
leg,  we  started  an  aggressive  therapy  with  pulse 
of  steroid  (methylprednosilone  500  mg/day)  for 
three  days  followed  by  prednisolone  60  mg  plus 
cyclophsphamide 750 mg stat and then each month, 
and also added adefovir 10 mg/day to lamivudine. 
After six months with this therapy, the cutaneous 
ulcers  healed  and  his  leg  ulcers  recovered.  It  has 
been suggested that incomplete therapy may delay 
improvement of PAN in association with HBV and 
the patient’s life may be in danger (7, 8).
High viral load may be resistant to the conventional 
antiviral monotherapy commonly used for hepatitis B 
infection, and this is why combination therapy with 
at least two antiviral drugs should be started as soon as 
possible as we did (9). Hepatitis B monotherapy with 
lamivudine may increase the likelihood of resistance 
to this drug in long run. Therefore, drug resistance 
of HBV should be considered if therapy fails (8). Low 
dose  prednisolone  cannot  prevent  progression  of Hepat Mon. 2010; 10(4): 306-309
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severe form of PAN as was the case in our patient who 
ultimately  required  high  dose  immunosuppressive 
therapy (9). Viral load may be an important predictor 
for the severity of PAN because when the viral load 
decreased  from  17,000,000  to  100,000  copy/mL 
after  therapy,  the  patient’s  condition  got  better. 
Superimposed  bacterial  infection  on  ulcers  can 
worsen the prognosis, cause seeding of bacteria in 
others organs and the patient is apt to develop sepsis. 
Therefore, superimposed bacterial infection should 
also be treated aggressively by appropriate antibiotics 
and/or surgical debridement (10). Peginterferon and 
plasmapheresis are optimal therapeutic modalities; 
however, we treated our patient with high doses of 
antiviral  and  immunosuppressives  and  achieved  a 
desirable response (11). 
In  patients  who  are  given  high  dose 
immunosuppressive  drugs,  some  latent  infectious 
diseases  should  be  considered  and  be  activated. 
Such  infections  include  tuberculosis,  toxoplasmosis 
and  molluscum  contagiosum  which  should  be 
treated  if  become  active.  All  differential  diagnoses 
of PAN should also be considered for planning the 
treatment (12). Cutaneous leishmaniasis is one of the 
differential diagnoses for cutaneous PAN, especially 
in endemic areas like Iran because chronic small skin 
ulcers of PAN resemble leishmaniasis lesions. While 
immunosuppressive therapy is good for the former 
condition, it may disseminate the latter. Fortunately, 
in  our  patient  smear  and  culture  for  leishmania 
were negative (13). Toxoplasma gondii is a ubiquitous 
protozoan parasite causing severe or life threatening 
infections in immunocompromised patients. Occult 
ocular toxoplasmosis may be activated in patients who 
take  high  dose  and  prolonged  immunosuppressive 
therapy. Toxoplasmosis is also endemic in our country. 
Our patient though had inactive ocular toxoplasmosis, 
did not get the active form of the disease during follow-
up, hence no therapy was required (14). 
Tuberculosis  can  involve  the  skin  and 
create  cutaneous  wounds  resembling  PAN. 
Immunosuppressive  therapy  may  activate  latent 
tuberculosis. Fortunately, our patient had negative 
PPD skin test and did not need any anti-tuberculosis 
therapy.  In  endemic  areas  for  tuberculosis, 
immunosuppressive  therapy  should  be  used  with 
caution (15). Molluscum contagiosum is a common 
self-limited  skin  condition.  However,  it  may  be 
disseminated  in  immunosuppressive  patients  or 
present  as  atypical  lesions,  although  some  of  the 
antiviral drugs such as cidofovir successfully treated 
severe  forms  of  molluscum  contagiosum.  In  our 
patient,  adefovir  may  have  prevented  activation 
of  molluscum  contagiosum  (16).  Some  malignant 
diseases  may  have  presentations  in  the  skin  and 
should  be  considered  in  the  differential  diagnosis 
for PAN which in our patient was found negative 
(17).  Pyoderma  gangrenosum  is  another  condition 
that resembles the skin lesions to be differentiated 
from  PAN.  Its  pathogenesis  is  not  known  but  it 
may  be  a  hyper-reactive  phenomenon.  Pyoderma 
gangrenosum can cause chronic skin wounds that 
rarely need steroid therapy except in severe form. 
However,  in  PAN,  the  small-  and  middle-sized 
arteries are involved that causes systemic vasculitis 
and steroid therapy is often needed (18). In 30% of 
patients with PAN, HBV infection is present, but no 
infection is seen in pyoderma gangrenosum (8, 19).
Leukocytoclastic vasculitis is another disease to 
be differentiated from PAN. This vasculitis is usually 
seen  in  inflammatory  bowel  disease  without  any 
relation to HBV infection. This differential diagnosis 
is very important since antiviral therapy is needed for 
PAN related to HBV (20). Chronic diseases in any 
patient  can  cause  disappointment  and  depression 
with resultant reduction in the quality of life such 
as what we observed in our patient. Therefore, this 
problem  also  should  be  considered  and  treated 
appropriately in a timely manner (21). 
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